Article Versions Notes

Ng HHL, Mahmood I, Aggrey F, Dearden H, Baxter M, Zucker K on behalf of the National Oncology Trainees Collaborative for Healthcare Research (NOTCH). CHEcking Diagnostic Differential Ability of Real Baseline Variables and Frailty Scores in Tolerance of Anti-Cancer Systemic Therapy in OldEr Patients (CHEDDAR-TOASTIE). Cancers. 2025; 17(20):3303. https://doi.org/10.3390/cancers17203303

Ng, Helen H. L., Isa Mahmood, Francis Aggrey, Helen Dearden, Mark Baxter, and Kieran Zucker on behalf of the National Oncology Trainees Collaborative for Healthcare Research (NOTCH). 2025. "CHEcking Diagnostic Differential Ability of Real Baseline Variables and Frailty Scores in Tolerance of Anti-Cancer Systemic Therapy in OldEr Patients (CHEDDAR-TOASTIE)" Cancers 17, no. 20: 3303. https://doi.org/10.3390/cancers17203303

Ng, H. H. L., Mahmood, I., Aggrey, F., Dearden, H., Baxter, M., & Zucker, K., on behalf of the National Oncology Trainees Collaborative for Healthcare Research (NOTCH). (2025). CHEcking Diagnostic Differential Ability of Real Baseline Variables and Frailty Scores in Tolerance of Anti-Cancer Systemic Therapy in OldEr Patients (CHEDDAR-TOASTIE). Cancers, 17(20), 3303. https://doi.org/10.3390/cancers17203303